Skip to main content

Featured

Dalai Lama Asserts Sole Authority Over Reincarnation Amid China’s Claims

In a landmark declaration just days before his 90th birthday, the Dalai Lama has reaffirmed that the centuries-old Tibetan Buddhist institution will continue after his death—and that his reincarnation will be determined solely by the Gaden Phodrang Trust , a foundation he established. This move directly challenges China’s long-standing assertion that it holds the final say in selecting the next Dalai Lama. Speaking in a pre-recorded message during a religious gathering in Dharamshala, India, the exiled spiritual leader stated that no external political power, including China, has any authority  to interfere in the reincarnation process. He emphasized that the search for his successor will follow traditional Tibetan Buddhist practices and be overseen by senior monks and spiritual advisors connected to the Trust. China swiftly responded, insisting that any reincarnation must be approved by Beijing and conducted within Chinese-administered Tibetan regions. Officials cited a Qing dynas...

article

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Comments